🇺🇸 FDA
Patent

US 8575375

Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

granted A61PA61P25/00A61P25/02

Quick answer

US patent 8575375 (Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P25/00, A61P25/02, A61P25/08, A61P25/22